EXECUTIVE CHAIRMAN’S AGREEMENTExecutive Chairman's Agreement • May 12th, 2015 • Volitionrx LTD • In vitro & in vivo diagnostic substances • Delaware
This EXECUTIVE CHAIRMAN’S AGREEMENT is dated March 31, 2015 (the “Agreement”) by and between VOLITIONRX LIMITED, a Delaware corporation (the “Company”), and DR. MARTIN CHARLES FAULKES, an individual resident in the United Kingdom (“Dr. Faulkes”).
Schedule no 1 to Master Consultancy Agreement between OncoLytika (‘the Consultancy’) and Volition (‘the Client’) dated 01 October 2010 (the ‘Master Agreement’)Master Consultancy Agreement • May 12th, 2015 • Volitionrx LTD • In vitro & in vivo diagnostic substances
INDEPENDENT DIRECTOR AGREEMENTIndependent Director Agreement • May 12th, 2015 • Volitionrx LTD • In vitro & in vivo diagnostic substances • Delaware
This INDEPENDENT DIRECTOR AGREEMENT is dated ___________ (the “Agreement”) by and between VOLITIONRX LIMITED, a Delaware corporation (the “Company”), and ___________, an individual resident in ___________ (the “Director”).
Schedule no 1 to Master Consultancy Agreement between OncoLytika (‘the Consultancy’) and Belgian Volition SA. (‘the Client’) dated 01 January 2014 (the ‘Master Agreement’)Master Consultancy Agreement • May 12th, 2015 • Volitionrx LTD • In vitro & in vivo diagnostic substances
